Acute liver failure is a refractory disease and its pro-gnosis, if not treated using liver transplantation, is extremely poor. It is a good candidate for regenerative medicine, where stem cell-based therapies play a central role. Mesenchymal stem cells(MSCs) are known to differentiate into multiple cell lineages including hepatocytes. Autologous cell transplant without any foreign gene induction is feasible using MSCs, thereby avoiding possible risks of tumorigenesis and immune rejection. Dental pulp also contains an MSC population that differentiates into hepatocytes. A point worthy of special mention is that dental pulp can be obtained from deciduous teeth during childhood and can be subsequently harvested when necessary after deposition in a tooth bank. MSCs have not only a regenerative capacity but also act in an anti--inflammatory manner via paracrine mechanisms. Promising efficacies and difficulties with the use of MSC derived from teeth are summarized in this review. Acute liver failure is a refractory disease and its pro-gnosis, if not treated using liver transplantation, is extremely poor. Mesenchymal stem cells (MSCs) are known to differentiate into multiple cell lineages including hepatocytes. Autologous cell transplant without any foreign gene induction is feasible using MSCs, thereby avoiding possible of of tumorigenesis and immune rejection. special mention is that that dental pulp can be obtained from deciduous teeth during childhood and can be harvested when necessary after deposition in a tooth bank. MSCs have not only regenerative capacity but also act in an anti- inflammatory manner via paracrine mechanisms. efficacies and difficulties with the use of MSC derived from teeth are summarized in this review.